Central inhibition of IKKβ/NF-κB signaling attenuates high-fat diet-induced obesity and glucose intolerance

Diabetes

Volumn 64, Issue 6, 2015, Pages 2015-2027

  Benzler, Jonas ^a   Ganjam, Goutham K ^a   Pretz, Dominik ^a   Oelkrug, Rebecca ^a   Koch, Christiane E ^a   Legler, Karen ^a   Stöhr, Sigrid ^a   Culmsee, Carsten ^a   Williams, Lynda M ^b   Tups, Alexander ^a,c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BUTEIN; GLUCOSE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; PARVOVIRUS VECTOR; SUPPRESSOR OF CYTOKINE SIGNALING 3; FAT INTAKE; GLUCOSE BLOOD LEVEL; I KAPPA B KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; BODY FAT; CONTROLLED STUDY; DIET INDUCED OBESITY; ENERGY EXPENDITURE; ENERGY METABOLISM; GENE OVEREXPRESSION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY; INSULIN TOLERANCE TEST; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; BODY COMPOSITION; CELL LINE; FAT INTAKE; GLUCOSE BLOOD LEVEL; IN SITU HYBRIDIZATION; METABOLISM; OBESITY; PHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; CELL LINE; DIETARY FATS; GLUCOSE INTOLERANCE; I-KAPPA B KINASE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICE; NF-KAPPA B; OBESITY; SIGNAL TRANSDUCTION;

EID: 84940107968     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0093     Document Type: Article

References (47)

1. Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006;17:4-12.
2. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: Epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-2140.
3. Brüning JC, Gautam D, Burks DJ, et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000;289:2122-2125.
4. Marks JL, Porte D Jr, Stahl WL, Baskin DG. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 1990;127:3234-3236.
5. Niswender KD, Morrison CD, Clegg DJ, et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: A key mediator of insulin-induced anorexia. Diabetes 2003;52:227-231.
6. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002;8:1376-1382.
7. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 2002;5:566-572.
8. Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I, Accili D. Transgenic rescue of insulin receptor-deficient mice. J Clin Invest 2004;114:214-223.
9. Okamoto H, Obici S, Accili D, Rossetti L. Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest 2005;115: 1314-1322.
10. De Souza CT, Araujo EP, Bordin S, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005;146:4192-4199.
11. Belgardt BF, Mauer J, Wunderlich FT, et al. Hypothalamic and pituitary c-Jun N- Terminal kinase 1 signaling coordinately regulates glucose metabolism. Proc Natl Acad Sci U S A 2010;107:6028-6033.
12. Benzler J, Ganjam GK, Legler K, et al. Acute inhibition of central c-Jun N- Terminal kinase restores hypothalamic insulin signalling and alleviates glucose intolerance in diabetic mice. J Neuroendocrinol 2013;25:446-454.
13. Posey KA, Clegg DJ, Printz RL, et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab 2009;296:E1003-E1012.
14. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008;135:61-73.
15. Cai D. NFkappaB-mediated metabolic inflammation in peripheral tissues versus central nervous system. Cell Cycle 2009;8:2542-2548.
16. Kleinridders A, Schenten D, Könner AC, et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab 2009;10:249-259.
17. Thaler JP, Yi CX, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 2012;122:153-162.
18. Baeuerle PA, Baltimore D. NF-kappa B: Ten years after. Cell 1996;87:13-20.
19. Vaughan S, Jat PS. Deciphering the role of nuclear factor-kB in cellular senescence. Aging (Albany, NY Online) 2011;3:913-919.
20. Purkayastha S, Zhang H, Zhang G, Ahmed Z, Wang Y, Cai D. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proc Natl Acad Sci U S A 2011;108:2939-2944.
21. Yan J, Zhang H, Yin Y, et al. Obesity- And aging-induced excess of central transforming growth factor-b potentiates diabetic development via an RNA stress response. Nat Med 2014;20:1001-1008.
22. Chuang CC, McIntosh MK. Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases. Annu Rev Nutr 2011;31:155-176.
23. Pandey MK, Sandur SK, Sung B, Sethi G, Kunnumakkara AB, Aggarwal BB. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NFkappaB- regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue. J Biol Chem 2007;282:17340-17350.
24. Wang Z, Lee Y, Eun JS, Bae EJ. Inhibition of adipocyte inflammation and macrophage chemotaxis by butein. Eur J Pharmacol 2014;738:40-48.
25. Gelling RW, Morton GJ, Morrison CD, et al. Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes. Cell Metab 2006;3:67-73.
26. Koch C, Augustine RA, Steger J, et al. Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity. J Neurosci 2010;30:16180-16187.
27. Tups A, Anderson GM, Rizwan M, et al. Both p110alpha and p110beta isoforms of phosphatidylinositol 3-OH-kinase are required for insulin signalling in the hypothalamus. J Neuroendocrinol 2010;22:534-542.
28. Kügler S, Lingor P, Schöll U, Zolotukhin S, Bähr M. Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. Virology 2003;311:89-95.
29. Benzler J, Ganjam GK, Krüger M, et al. Hypothalamic glycogen synthase kinase 3b has a central role in the regulation of food intake and glucose metabolism. Biochem J 2012;447:175-184.
30. Lotharius J, Falsig J, van Beek J, et al. Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 2005;25: 6329-6342.
31. Heldmaier G, Ruf T. Body temperature and metabolic rate during natural hypothermia in endotherms. J Comp Physiol B 1992;162:696-706.
32. Mercer JG, Moar KM, Logie TJ, Findlay PA, Adam CL, Morgan PJ. Seasonally inappropriate body weight induced by food restriction: Effect on hypothalamic gene expression in male Siberian hamsters. Endocrinology 2001;142: 4173-4181.
33. Paxinos G, Franklin K. The Mouse Brain in Stereotaxic Coordinates. (2). San Diego, CA, Academics, 2002.
34. Bjørbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998;1:619-625.
35. Tups A, Ellis C, Moar KM, et al. Photoperiodic regulation of leptin sensitivity in the Siberian hamster, Phodopus sungorus, is reflected in arcuate nucleus SOCS-3 (suppressor of cytokine signaling) gene expression. Endocrinology 2004; 145:1185-1193.
36. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444: 860-867.
37. Milanski M, Degasperi G, Coope A, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 2009;29:359-370.
38. Thaler JP, Schwartz MW. Minireview: inflammation and obesity pathogenesis: The hypothalamus heats up. Endocrinology 2010;151:4109-4115.
39. Yu Y, Wu Y, Szabo A, et al. Teasaponin reduces inflammation and central leptin resistance in diet-induced obese male mice. Endocrinology 2013;154: 3130-3140.
40. Monahan PE, Samulski RJ. AAV vectors: is clinical success on the horizon? Gene Ther 2000;7:24-30.
41. Wang J, Faust SM, Rabinowitz JE. The next step in gene delivery: molecular engineering of adeno- Associated virus serotypes. J Mol Cell Cardiol 2011;50: 793-802.
42. Milanski M, Arruda AP, Coope A, et al. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 2012; 61:1455-1462.
43. Kievit P, Howard JK, Badman MK, et al. Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab 2006;4:123-132.
44. Hill JW, Williams KW, Ye C, et al. Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. J Clin Invest 2008; 118:1796-1805.
45. German J, Kim F, Schwartz GJ, et al. Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology 2009;150:4502-4511.
46. Hedbacker K, Birsoy K, Wysocki RW, et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab 2010;11:11-22.
47. Hwa JJ, Fawzi AB, Graziano MP, et al. Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice. Am J Physiol 1997;272: R1204-R1209.